Cetrimonium bromide
This article was originally published in The Tan Sheet
Executive Summary
FDA seeks safety data on the ingredient, which is used in products such as underarm deodorants, suntan preps and other skin care items. At a May 24-25 meeting in Arlington, Va., the Cosmetic Ingredient Review determined that the information needed to make a safety assessment on cetrimonium bromide includes impurity data, a 28-day dermal toxicity study, two genotoxicity studies, and human irritation and sensitization data.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning